Comment on "Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus (Pancreas. 2008;36:274-278)"

Pancreas

Volumn 38, Issue 4, 2009, Pages 471-472

  Hardt, Philip D ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CERULETIDE; ELASTASE; ELASTASE I; MONOCLONAL ANTIBODY; PANCREAS ENZYME; POLYCLONAL ANTIBODY; SECRETIN; UNCLASSIFIED DRUG; PANCREATIC ELASTASE;

FECES LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; PANCREAS EXOCRINE INSUFFICIENCY; PANCREAS FUNCTION TEST; PRIORITY JOURNAL; STEATORRHEA; ENZYMOLOGY; FECES; METABOLISM; NOTE; PATHOPHYSIOLOGY;

DIABETES MELLITUS, TYPE 1; EXOCRINE PANCREATIC INSUFFICIENCY; FECES; HUMANS; PANCREATIC ELASTASE; PANCREATIC FUNCTION TESTS;

EID: 66149133679     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31818b0060     Document Type: Letter

References (10)

1. Hahn JU, Kerner W, Maisonneuve P, et al. Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus. Pancreas. 2008;36: 274-278.
2. Icks A, Haastert B, Giani G, et al. Low fecal elastase-1 in type I diabetes mellitus. Z Gastroenterol. 2001;39:823-830.
3. Hardt PD, Hauenschild A, Nalop J, et al. High prevalence of exocrine pancreatic insufficiency in diabetes mellitus. A multicenter study screening fecal elastase 1 concentrations in 1,021 diabetic patients. Pancreatology. 2003;3:395-402.
4. Hardt PD, Brendel MD, Kloer HU, et al. Is pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed? Diabetes Care. 2008;31:S165-S169.
5. Stein J, Spirchez Z, Lembcke B, et al. Investigations to the diagnostic value of elastase 1 test. Z Gastroenterol. 1997; (suppl 1):122-129.
6. Löser C, Möllgaard A, Fölsch UR. Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut. 1996;39:580-586.
7. Hardt PD, Marzeion AM, Schnell-Kretschmer H, et al. Fecal elastase 1 measurement compared with endoscopic retrograde cholangiopancreatography for the diagnosis of chronic pancreatitis. Pancreas. 2002;25: e6-e9.
8. Hardt PD, Hauenschild A, Jaeger C, et al. High prevalence of steatorrhea in 101 diabetic patients likely to suffer fromexocrine pancreatic insufficiency according to low fecal elastase 1 concentrations: a prospective multicenter study. Dig Dis Sci. 2003;48: 1688-1692.
9. Lankisch PG, Schmidt I, König H, et al. Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency. Gut. 1998;42:551-554.
10. Hardt PD, Hauenschild A, Nalop J, et al. The commercially available ELISA for pancreatic elastase 1 based on polyclonal antibodies does measure an as yet unknown antigen different from purified elastase 1. Binding studies and clinical use in patients with exocrine pancreatic insufficiency. Z Gastroenterol. 2003;41:903-906.